This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Louis, D. N. Articles by Seizinger, B. R. Search for Related Content PubMed PubMed Citation Articles by Louis, D. N. Articles by Seizinger, B. R.

American Journal of Pathology, Vol 141, 777-782, Copyright © 1992 by American Society for Investigative Pathology

REGULAR ARTICLES

A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens

DN Louis, A von Deimling and BR Seizinger
Department of Pathology (Neuropathology), Massachusetts General Hospital, Boston 02114.

Southern blotting is a widely used method of determining loss of chromosomal alleles in tumors, but cannot be used to analyze small biopsies and most fixed, embedded tissues. These problems preclude analysis of many surgical neuropathology specimens. We have employed a polymerase chain reaction assay for loss of heterozygosity (LOH) based on the (CA)n dinucleotide repeat polymorphisms found in abundance throughout the human genome. We compared this method to conventional Southern blotting in detecting LOH on chromosome 10 in gliomas. From tissue sections of 14 paraffin-embedded, formalin-fixed gliomas, we amplified the (CA)n repeat D10S89 locus and compared (CA)n repeat patterns between tumor DNA and constitutional DNA. Loss of one chromosome 10 (CA)n repeat allele was seen in informative glioblastomas that showed allelic loss by Southern blotting, but not in gliomas that had maintained both alleles. The (CA)n repeat method can be applied to small and fixed, embedded specimens, is rapid and simple to perform, and uses highly polymorphic probes. We suggest that (CA)n repeats are a less exclusive and more rapid means of studying LOH in brain tumors than Southern blotting, and will provide further mapping data for the identification of tumor suppressor genes integral to glial tumorigenesis.

This article has been cited by other articles:

				G. Mohapatra, R. A. Betensky, E. R. Miller, B. Carey, L. D. Gaumont, D. A. Engler, and D. N. Louis Glioma Test Array for Use with Formalin-Fixed, Paraffin-Embedded Tissue: Array Comparative Genomic Hybridization Correlates with Loss of Heterozygosity and Fluorescence in Situ Hybridization J. Mol. Diagn., May 1, 2006; 8(2): 268 - 276. [Abstract] [Full Text] [PDF]

				J. F. Megyesi, E. Kachur, D. H. Lee, M. C. Zlatescu, R. A. Betensky, P. A. Forsyth, Y. Okada, H. Sasaki, M. Mizoguchi, D. N. Louis, et al. Imaging Correlates of Molecular Signatures in Oligodendrogliomas Clin. Cancer Res., July 1, 2004; 10(13): 4303 - 4306. [Abstract] [Full Text] [PDF]

				T. T. Batchelor, R. A. Betensky, J. M. Esposito, L.-D. D. Pham, M. V. Dorfman, N. Piscatelli, S. Jhung, D. Rhee, and D. N. Louis Age-Dependent Prognostic Effects of Genetic Alterations in Glioblastoma Clin. Cancer Res., January 1, 2004; 10(1): 228 - 233. [Abstract] [Full Text] [PDF]

				K. Farrand, L. Jovanovic, B. Delahunt, B. McIver, I. D. Hay, N. L. Eberhardt, and S. K. G. Grebe Loss of Heterozygosity Studies Revisited: Prior Quantification of the Amplifiable DNA Content of Archival Samples Improves Efficiency and Reliability J. Mol. Diagn., August 1, 2002; 4(3): 150 - 158. [Abstract] [Full Text] [PDF]

				W. Mueller, C. Hartmann, A. Hoffmann, W. Lanksch, J. Kiwit, J. Tonn, J. Veelken, J. Schramm, M. Weller, O. D. Wiestler, et al. Genetic Signature of Oligoastrocytomas Correlates with Tumor Location and Denotes Distinct Molecular Subsets Am. J. Pathol., July 1, 2002; 161(1): 313 - 319. [Abstract] [Full Text] [PDF]

				H. Sasaki, R. A. Betensky, J. G. Cairncross, and D. N. Louis DMBT1 Polymorphisms: Relationship to Malignant Glioma Tumorigenesis Cancer Res., March 1, 2002; 62(6): 1790 - 1796. [Abstract] [Full Text] [PDF]

				M. C. Zlatescu, A. TehraniYazdi, H. Sasaki, J. F. Megyesi, R. A. Betensky, D. N. Louis, and J. G. Cairncross Tumor Location and Growth Pattern Correlate with Genetic Signature in Oligodendroglial Neoplasms Cancer Res., September 1, 2001; 61(18): 6713 - 6715. [Abstract] [Full Text] [PDF]

				H. Sasaki, M. C. Zlatescu, R. A. Betensky, Y. Ino, J. G. Cairncross, and D. N. Louis PTEN Is a Target of Chromosome 10q Loss in Anaplastic Oligodendrogliomas and PTEN Alterations Are Associated with Poor Prognosis Am. J. Pathol., July 1, 2001; 159(1): 359 - 367. [Abstract] [Full Text] [PDF]

				Y. Ino, R. A. Betensky, M. C. Zlatescu, H. Sasaki, D. R. Macdonald, A. O. Stemmer-Rachamimov, D. A. Ramsay, J. G. Cairncross, and D. N. Louis Molecular Subtypes of Anaplastic Oligodendroglioma: Implications for Patient Management at Diagnosis Clin. Cancer Res., April 1, 2001; 7(4): 839 - 845. [Abstract] [Full Text]

				M. A. Dickson, W. C. Hahn, Y. Ino, V. Ronfard, J. Y. Wu, R. A. Weinberg, D. N. Louis, F. P. Li, and J. G. Rheinwald Human Keratinocytes That Express hTERT and Also Bypass a p16INK4a-Enforced Mechanism That Limits Life Span Become Immortal yet Retain Normal Growth and Differentiation Characteristics Mol. Cell. Biol., February 15, 2000; 20(4): 1436 - 1447. [Abstract] [Full Text]

				D.A. Weaver, T.K. Hei, B. Hukku, J.P. Demuth, E.L. Crawford, J.A. Mcraven, S. Girgis, and J.C. Willey Localization of tumor suppressor gene candidates by cytogenetic and short tandem repeat analyses in tumorigenic human bronchial epithelial cells Carcinogenesis, February 1, 2000; 21(2): 205 - 211. [Abstract] [Full Text] [PDF]

				G. P. Nielsen, A. O. Stemmer-Rachamimov, Y. Ino, M. B. Moller, A. E. Rosenberg, and D. N. Louis Malignant Transformation of Neurofibromas in Neurofibromatosis 1 Is Associated with CDKN2A/p16 Inactivation Am. J. Pathol., December 1, 1999; 155(6): 1879 - 1884. [Abstract] [Full Text] [PDF]

				C. Ebert, M. von Haken, B. Meyer-Puttlitz, O. D. Wiestler, G. Reifenberger, T. Pietsch, and A. von Deimling Molecular Genetic Analysis of Ependymal Tumors : NF2 Mutations and Chromosome 22q Loss Occur Preferentially inIntramedullary Spinal Ependymomas Am. J. Pathol., August 1, 1999; 155(2): 627 - 632. [Abstract] [Full Text] [PDF]

				J. Jen, H. Kim, S. Piantadosi, Z.-F. Liu, R. C. Levitt, P. Sistonen, K. W. Kinzler, B. Vogelstein, and S. R. Hamilton Allelic Loss of Chromosome 18q and Prognosis in Colorectal Cancer N. Engl. J. Med., July 28, 1994; 331(4): 213 - 221. [Abstract] [Full Text]